Physician profile
Christopher R Accetta
NPI 1407820384
$4,879.93
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $442 · 2021: $747 · 2022: $1,632 · 2023: $1,362 · 2024: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,346.88 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Sumitomo Pharma America, INC. | $477.31 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $392.10 | 2019-2023 | Thinprep 2000 Processor, Aptima |
| Channel Medsystems, INC. | $243.86 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $243.82 | 2022-2024 | |
| Therapeuticsmd, INC. | $241.22 | 2019-2022 | |
| Exeltis, USA INC. | $235.38 | 2021-2024 | Slynd |
| Myovant Sciences INC. | $220.47 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $145.02 | 2021-2022 | |
| Pfizer INC. | $144.62 | 2019-2023 | |
| Organon LLC | $143.04 | 2021-2024 | Nexplanon |
| Evofem Biosciences, INC. | $133.66 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.44 | 2019-2023 | |
| Avion Pharmaceuticals | $90.28 | 2019-2022 | |
| Shield Therapeutics INC | $74.33 | 2022-2023 | Accrufer |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $67.10 | 2022 | |
| Optumhealth Care Solutions, LLC | $63.01 | 2023-2024 | Zyno Solutions, Vivify Health Care Team Portal, Eitan Medical |
| Merck Sharp & Dohme LLC | $62.99 | 2019-2020 | |
| Duchesnay USA Incorporated | $55.41 | 2019-2020 | |
| Agile Therapeutics, INC. | $52.16 | 2021-2022 | |
| Lupin INC. | $39.18 | 2019-2020 | |
| Coopersurgical, INC. | $35.81 | 2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Exact Sciences Corporation | $35.14 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $35.01 | 2023 | Veozah |
| Allergan, INC. | $34.91 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $27.81 | 2019-2020 | |
| Ethicon US, LLC | $22.05 | 2024 | Stratafix, Enseal, Ethicon |
| Alexion Pharmaceuticals, INC. | $22.00 | 2019 | |
| Aspira Women'S Health INC | $19.54 | 2022 | |
| Sage Therapeutics, LLC | $18.69 | 2020 | |
| Axonics, INC. | $14.98 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.97 | 2022 | |
| Gynesonics, INC. | $13.74 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Accetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.